Journal article
Enhanced radiation sensitivity in HPV-positive head and neck cancer
Cancer research (Chicago, Ill.), Vol.73(15), pp.4791-4800
08/01/2013
DOI: 10.1158/0008-5472.can-13-0587
PMCID: PMC3732540
PMID: 23749640
Abstract
Patients with human papillomavirus (HPV+)-associated head and neck cancer (HNC) show significantly improved survival outcome compared with those with HPV-negative (HPV-) tumors. Published data examining this difference offers conflicting results to date. We systematically investigated the radiation sensitivity of all available validated HPV+ HNC cell lines and a series of HPV- HNC cell lines using in vitro and in vivo techniques. HPV+ HNCs exhibited greater intrinsic radiation sensitivity (average SF2 HPV-: 0.59 vs. HPV+: 0.22; P < 0.0001), corresponding with a prolonged G2-M cell-cycle arrest and increased apoptosis following radiation exposure (percent change 0% vs. 85%; P = 0.002). A genome-wide microarray was used to compare gene expression 24 hours following radiation between HPV+ and HPV- cell lines. Multiple genes in TP53 pathway were upregulated in HPV+ cells (Z score 4.90), including a 4.6-fold increase in TP53 (P < 0.0001). Using immortalized human tonsillar epithelial (HTE) cells, increased radiation sensitivity was seen in cell expressing HPV-16 E6 despite the effect of E6 to degrade p53. This suggested that low levels of normally functioning p53 in HPV+ HNC cells could be activated by radiation, leading to cell death. Consistent with this, more complete knockdown of TP53 by siRNA resulted in radiation resistance. These results provide clear evidence, and a supporting mechanism, for increased radiation sensitivity in HPV+ HNC relative to HPV- HNC. This issue is under active investigation in a series of clinical trials attempting to de-escalate radiation (and chemotherapy) in selected patients with HPV+ HNC in light of their favorable overall survival outcome.
Details
- Title: Subtitle
- Enhanced radiation sensitivity in HPV-positive head and neck cancer
- Creators
- Randall J Kimple - Department of Human Oncology, University of Wisconsin Comprehensive Cancer Center, 3107 WIMR, 1111 Highland Avenue, Madison, WI 53705, USA. rkimple@humonc.wisc.eduMolly A SmithGrace C BlitzerAlexandra D TorresJoshua A MartinRobert Z YangChimera R PeetLaurel D LorenzKwangok P NickelAloysius J KlingelhutzPaul F LambertPaul M Harari
- Resource Type
- Journal article
- Publication Details
- Cancer research (Chicago, Ill.), Vol.73(15), pp.4791-4800
- DOI
- 10.1158/0008-5472.can-13-0587
- PMID
- 23749640
- PMCID
- PMC3732540
- NLM abbreviation
- Cancer Res
- ISSN
- 1538-7445
- eISSN
- 1538-7445
- Publisher
- United States
- Grant note
- T32 CA009135 / NCI NIH HHS R01 CA113448 / NCI NIH HHS K99 CA160639 / NCI NIH HHS R00 CA160639 / NCI NIH HHS T32 AI078985 / NIAID NIH HHS R01 CA 113448 / NCI NIH HHS P30 CA014520 / NCI NIH HHS R01 DE017315 / NIDCR NIH HHS
- Language
- English
- Date published
- 08/01/2013
- Academic Unit
- Microbiology and Immunology; Radiation Oncology
- Record Identifier
- 9984001133202771
Metrics
22 Record Views